Mustafa Taştan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mustafa Taştan has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Seher Yilmaz
Department of Anatomy, Faculty of Medicine, Yozgat Bozok University, Yozgat 66100, Turkey
4 shared publications - Şükrü Ateş
Department of Anatomy, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey
4 shared publications - Adem Tokpinar
Department of Anatomy, Faculty of Medicine, Ordu University, Ordu, Türkiye
3 shared publications - Harun Ülger
Department of Anatomy, Faculty of Medicine, Erciyes University, Kayseri, Turkey
3 shared publications - Özge Al
Erciyes University, Faculty of Medicine, Department of Anatomy, Kayseri, Türkiye; Betul Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Türkiye
3 shared publications - Dilara Patat
Ankara Medipol University
2 shared publications
Latest Publications
- 2 May 2025
- Published by Academician Publishing
- p. 79-96
Chiari Malformasyonlarının Radyolojik Tarihçesi ve Güncel Volumetrik Yaklaşımlar
- 2 May 2025
- Published by Academician Publishing
- p. 79-96
Chiari Malformasyonlarının Radyolojik Tarihçesi ve Güncel Volumetrik Yaklaşımlar
- Open Access
- 2 May 2025
- Published by Academician Publishing
Chiari Malformasyonları
Chiari Malformasyonu Tarihçesi, Sınıflandırmaları Hidayet AKDEMİR Chiari Malformasyonları Bağlantılı Doku ve Organların Embriyonal Gelişim Süreçleri Ayhan BİLİR Posterior Fossa ve Kraniyovertebral Anatomi Ahmet KALAYCIOĞLU Nureda NALÇACI BOZKURT Chiari Malformasyonlarında Klinik Semptom ve Bulgular, Ayırıcı Tanı ve Klinik Testler Ali Osman MUÇUOĞLU Chiari Malformasyonlarının Radyolojik Tarihçesi ve Güncel Volumetrik Yaklaşımlar Niyazi ACER Mustafa TAŞTAN Chiari Malformasyonları Elektrofizyoloji Demet AYGÜN ÜSTEL Ailesel Chiari Malformasyonu Oya AKÇA Hilal ŞAHİN Emre TEPELİ Pediatrik Chiari Malformasyonları Nazlı ÇAKICI ÖKSÜZ Chiari Malformasyonunda Epidemiyoloji, Konservatif Tedaviler ve Gebelikte Hasta Yönetimi Meltem CAN İKE Chiari Malformasyonları Cerrahi Tedavisinin Tarihçesi ve Güncel Yaklaşımlar Hidayet AKDEMİR Chiari Tip I Malformasyonunda Dural Dış Tabakanın Alınması ile Dekompresyon Rahmi Kemal KOÇ Halil ULUTABANCA Chiari Malformasyonları ve Baziller İnvaginasyon Ebubekir AKPINAR İlhan YILMAZ Chiari Malformasyonu ve Siringomiyeli Hidayet AKDEMİR Chiari Malformasyonu Cerrahisinin Komplikasyonları Hüseyin DOĞU Chiari Malformasyonu: Aile Rehberi Hidayet AKDEMİR
- 2 May 2025
- Published by Academician Publishing
Open AccessChiari Malformasyonları
Chiari Malformasyonu Tarihçesi, Sınıflandırmaları Hidayet AKDEMİR Chiari Malformasyonları Bağlantılı Doku ve Organların Embriyonal Gelişim Süreçleri Ayhan BİLİR Posterior Fossa ve Kraniyovertebral Anatomi Ahmet KALAYCIOĞLU Nureda NALÇACI BOZKURT Chiari Malformasyonlarında Klinik Semptom ve Bulgular, Ayırıcı Tanı ve Klinik Testler Ali Osman MUÇUOĞLU Chiari Malformasyonlarının Radyolojik Tarihçesi ve Güncel Volumetrik Yaklaşımlar Niyazi ACER Mustafa TAŞTAN Chiari Malformasyonları Elektrofizyoloji Demet AYGÜN ÜSTEL Ailesel Chiari Malformasyonu Oya AKÇA Hilal ŞAHİN Emre TEPELİ Pediatrik Chiari Malformasyonları Nazlı ÇAKICI ÖKSÜZ Chiari Malformasyonunda Epidemiyoloji, Konservatif Tedaviler ve Gebelikte Hasta Yönetimi Meltem CAN İKE Chiari Malformasyonları Cerrahi Tedavisinin Tarihçesi ve Güncel Yaklaşımlar Hidayet AKDEMİR Chiari Tip I Malformasyonunda Dural Dış Tabakanın Alınması ile Dekompresyon Rahmi Kemal KOÇ Halil ULUTABANCA Chiari Malformasyonları ve Baziller İnvaginasyon Ebubekir AKPINAR İlhan YILMAZ Chiari Malformasyonu ve Siringomiyeli Hidayet AKDEMİR Chiari Malformasyonu Cerrahisinin Komplikasyonları Hüseyin DOĞU Chiari Malformasyonu: Aile Rehberi Hidayet AKDEMİR
- 5 November 2024
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 13 (6) , tfae207
In vitro effect of vitaminB12 on embyro growth by induction of hypoxia in culture
In this study, effects of vitaminB12 on embryonic development have been investigated by supplying vitaminB12 on a hypoxia-induced embryo culture. 9.5-day-old embryos from Wistar albino adult pregnant rats were used in our experimental set up.10 μM and 100 μM vitaminB12 were added to culture medium which is then exposed to in vitro hypoxia. Additionally, 11.5-day-old embryos and yolksacs were examined morphologically. Different vitaminB12 doses are compared within experimental groups. It was found that both control and experimental groups in 11.5-day-old embryos are at same developmental stage. It was also determined that oxygen deficiency influenced embryonic development and yolk sac vascularity in hypoxia group, are lagging behind in all experimental groups (P < 0.05). However, the development of vitaminB12 embryos were similar to control group under normoxic conditions (P > 0.05). It was also observed that development was compensated through supplement of vitaminB12 to hypoxia group (P < 0.05). It was indicated that the development in H + 100 μM vitB12 groups was quite close to control group. However, development of H + 10 μM vitB12 embryos were in parallel with hypoxic group. Furthermore, H + 100 μM vitB12 group showed higher embryonic development than H + 10 μM vitB12 group (P < 0.05).VitaminB12 treatment has been used to prevent intrauterine growth restriction which can be caused by many different pharmacological agents. However, nobody has investigated effects of vitaminB12 on hypoxia-induced early embryo growth retardation. In the light of our findings, administration of 100 μM vitaminB12 restores damage of embryonic development due to hypoxia and this application also increases embryonic vascularity and circulation. Thus, supplementation of vitaminB12 can be offered as a therapeutic approach towards cell death and diseases such as neurovascular and cardiovascular diseases and in the near future.
- 5 November 2024
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 13 (6) , tfae207
In vitro effect of vitaminB12 on embyro growth by induction of hypoxia in culture
In this study, effects of vitaminB12 on embryonic development have been investigated by supplying vitaminB12 on a hypoxia-induced embryo culture. 9.5-day-old embryos from Wistar albino adult pregnant rats were used in our experimental set up.10 μM and 100 μM vitaminB12 were added to culture medium which is then exposed to in vitro hypoxia. Additionally, 11.5-day-old embryos and yolksacs were examined morphologically. Different vitaminB12 doses are compared within experimental groups. It was found that both control and experimental groups in 11.5-day-old embryos are at same developmental stage. It was also determined that oxygen deficiency influenced embryonic development and yolk sac vascularity in hypoxia group, are lagging behind in all experimental groups (P < 0.05). However, the development of vitaminB12 embryos were similar to control group under normoxic conditions (P > 0.05). It was also observed that development was compensated through supplement of vitaminB12 to hypoxia group (P < 0.05). It was indicated that the development in H + 100 μM vitB12 groups was quite close to control group. However, development of H + 10 μM vitB12 embryos were in parallel with hypoxic group. Furthermore, H + 100 μM vitB12 group showed higher embryonic development than H + 10 μM vitB12 group (P < 0.05).VitaminB12 treatment has been used to prevent intrauterine growth restriction which can be caused by many different pharmacological agents. However, nobody has investigated effects of vitaminB12 on hypoxia-induced early embryo growth retardation. In the light of our findings, administration of 100 μM vitaminB12 restores damage of embryonic development due to hypoxia and this application also increases embryonic vascularity and circulation. Thus, supplementation of vitaminB12 can be offered as a therapeutic approach towards cell death and diseases such as neurovascular and cardiovascular diseases and in the near future.
- 4 January 2022
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 23 (1) , 241-249
The protective effect of Myrtus communis L. against experimental kidney stone in rats
- 4 January 2022
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 23 (1) , 241-249
The protective effect of Myrtus communis L. against experimental kidney stone in rats
- Open Access
- 1 January 2022
- Published by Walter de Gruyter GmbH in Postępy Higieny I Medycyny Doświadczalnej
- Vol. 76 (1) , 431-443
Investigation of the effect of yarrow ( Achillea millefolium ) on Ehrlich ascites tumor
Introduction: One of the most important health problems today is cancer. The aim of this study was to investigate the in vitro effect of yarrow (Y) with known anticarcinogenic effect on Ehrlich ascites tumor (EAT). Materials and Methods: The above-ground part (300 g) of Y was macerated with water and extracted three times for 24 hours at 37°C in a shaking water bath. In the study, EAT cells were divided into control, DMSO group 5-FU, 50, 100, 200, 400 and 800 μg/ml YP groups. Results: At the end of the hour, it was observed that total apoptosis increased significantly in Y groups (especially 50 μg/ml) compared to the control group ( p ). It was observed that Y slowed the division of EAT cells (especially 800 μg/ml) by stopping the cell cycle at the G0/G1 stage. It was concluded that Y (especially at high doses) triggered apoptosis by significantly increasing the percentage of total depolarized cells (p ) in all three time periods. Conclusions: The results obtained showed that Y extract may have an antitumoral effect on EAT cells. It is thought that this study will contribute to studies on cancer treatment.
- 1 January 2022
- Published by Walter de Gruyter GmbH in Postępy Higieny I Medycyny Doświadczalnej
- Vol. 76 (1) , 431-443
Open AccessInvestigation of the effect of yarrow ( Achillea millefolium ) on Ehrlich ascites tumor
Introduction: One of the most important health problems today is cancer. The aim of this study was to investigate the in vitro effect of yarrow (Y) with known anticarcinogenic effect on Ehrlich ascites tumor (EAT). Materials and Methods: The above-ground part (300 g) of Y was macerated with water and extracted three times for 24 hours at 37°C in a shaking water bath. In the study, EAT cells were divided into control, DMSO group 5-FU, 50, 100, 200, 400 and 800 μg/ml YP groups. Results: At the end of the hour, it was observed that total apoptosis increased significantly in Y groups (especially 50 μg/ml) compared to the control group ( p ). It was observed that Y slowed the division of EAT cells (especially 800 μg/ml) by stopping the cell cycle at the G0/G1 stage. It was concluded that Y (especially at high doses) triggered apoptosis by significantly increasing the percentage of total depolarized cells (p ) in all three time periods. Conclusions: The results obtained showed that Y extract may have an antitumoral effect on EAT cells. It is thought that this study will contribute to studies on cancer treatment.
- Open Access
- 1 January 2022
- Published by Walter de Gruyter GmbH in Postępy Higieny I Medycyny Doświadczalnej
- Vol. 76 (1) , 209-219
Evaluation of antitumoral effect of mistletoe fruit extract on Ehrlich ascites tumor cells with muse cell analyzer and argyrophilic nucleolar organizer region staining method
Introduction: Mistletoe has been used alone or as a complementary therapy in the treatment of different diseases for years. In this study, the antitumoral effect of mistletoe fruit extract on Ehrlich ascites tumor (EAT) cells was evaluated. Materials and Methods: EAT cells from preformed stock mice were transferred to culture dishes containing 5-fluorouracil (5-FU) and mistletoe extracts at different doses (100, 200, 400, and 800 μg/ml). These cells were incubated at 37 °C in an environment with 95% humidity and 5% CO2. At the end of the incubations, the apoptosis status of the cells, cell cycle, mitochondrial membrane potential, and proliferation status with the argyrophilic (Ag) nucleolar organizer region staining (NORs) method were evaluated. Results: As a result, it was observed that the mistletoe fruit extract and 5-FU induce apoptosis of EAT cells. It was concluded that the 5-FU substance arrests the cell cycle at the G0/G1 stage, while the mistletoe arrests the cell cycle at the S and G2/M stages. The depolarization rate of the mistletoe treated cells was higher. As a result of the evaluation made with the AgNORs method, it was seen that mistletoe and 5-FU could be effective in reducing the proliferation of EAT cells. Conclusions: It was seen that mistletoe fruit extract could be effective in stimulating the apoptosis and depolarization of cancer cells. The results of other studies in the literature and our study support each other. It was concluded that the mistletoe plant may be useful in cancer treatment.
- 1 January 2022
- Published by Walter de Gruyter GmbH in Postępy Higieny I Medycyny Doświadczalnej
- Vol. 76 (1) , 209-219
Open AccessEvaluation of antitumoral effect of mistletoe fruit extract on Ehrlich ascites tumor cells with muse cell analyzer and argyrophilic nucleolar organizer region staining method
Introduction: Mistletoe has been used alone or as a complementary therapy in the treatment of different diseases for years. In this study, the antitumoral effect of mistletoe fruit extract on Ehrlich ascites tumor (EAT) cells was evaluated. Materials and Methods: EAT cells from preformed stock mice were transferred to culture dishes containing 5-fluorouracil (5-FU) and mistletoe extracts at different doses (100, 200, 400, and 800 μg/ml). These cells were incubated at 37 °C in an environment with 95% humidity and 5% CO2. At the end of the incubations, the apoptosis status of the cells, cell cycle, mitochondrial membrane potential, and proliferation status with the argyrophilic (Ag) nucleolar organizer region staining (NORs) method were evaluated. Results: As a result, it was observed that the mistletoe fruit extract and 5-FU induce apoptosis of EAT cells. It was concluded that the 5-FU substance arrests the cell cycle at the G0/G1 stage, while the mistletoe arrests the cell cycle at the S and G2/M stages. The depolarization rate of the mistletoe treated cells was higher. As a result of the evaluation made with the AgNORs method, it was seen that mistletoe and 5-FU could be effective in reducing the proliferation of EAT cells. Conclusions: It was seen that mistletoe fruit extract could be effective in stimulating the apoptosis and depolarization of cancer cells. The results of other studies in the literature and our study support each other. It was concluded that the mistletoe plant may be useful in cancer treatment.
- 1 June 2020
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
MORPHOMETRIC INVESTIGATION OF ANATOMIC STRUCTURES ON HUMERUS
Giriş: Humerus; Skapula, radius ve ulna kemikleri arasında bulunur ve üst ekstremitenin en uzun ve en kalın kemiğidir. Bu çalışma, cerrahi işlemler, ortez ve protez uygulamaları, humerusta morfometrik ve antropometrik ölçümler için bir kriter olacaktır.Gereç ve yöntem: Bu çalışma, 80 (56 sol, 24 sağ) kuru humerus kemik örneklerinde 0.01 milimetre (mm) hassasiyetinde dijital kumpas kullanılarak yapıldı. Kemik örneklerinde yaş ve cinsiyet ayrımı yapılmadı. Humerus üzerinde sulcus intertubercularis uzunluğu, minimum gövde çapı, maksimum gövde çapı, kapitulum humer, troclea humeri gibi 21 parametre ölçüldü.Bulgular: Çalışmamızın sonuçlarına göre humerusun maksimum uzunluğu (HMU); solda ortalama 31,16 ± 2,44 mm ve sağda 29,85 ± 3,08 mm. Minimum gövde çapı (MinGW); Solda 17,62 ± 2,18 mm ve sağda 17,84 ± 1,82 mm’dir.Sonuç: Humerus kemiğinin normal anatomik yapısını bilmek ve bu bölgedeki cerrahi prosedürleri ve protez uygulamalarını yönlendirmek için bu kemikteki anatomik yapıların ortalama değerlerini hesaplamak çok önemlidir. Introduction: Humerus; It is located between the scapula, radius and ulna bones and is the longest and thickest bone of the upper extremity. This study will be a criterion for surgical procedures, orthosis and prosthesis applications, morphometric and anthropometric measurements on humerus.Materials and methods: This study was carried out using digital calipers with sensitivity of 0.01 millimeters (mm) on dry humerus bone specimens of 80 (56 left, 24 right). Age and sex were not differentiated in bone samples. Sulcus intertubercularis length, minimum trunk diameter, maximum trunk diameter, capitulum humer, troclea humer were measured on the humerus as 21 parameters.Results: According to the results of our study, the maximum length of the humerus (HMU); mean 31.16 ± 2.44 mm on the left and 29.85 ± 3.08 mm on the right. Minimum body diameter (MinGW); 17,62 ± 2,18 mm on the left and 17,84 ± 1,82 mm on the rightConclusion: It is very important to know the normal anatomical structure of the humerus bone and to calculate the average values of the anatomical structures on this bone in order to guide the surgical procedures and prosthesis applications in this region.
- 1 June 2020
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
MORPHOMETRIC INVESTIGATION OF ANATOMIC STRUCTURES ON HUMERUS
Giriş: Humerus; Skapula, radius ve ulna kemikleri arasında bulunur ve üst ekstremitenin en uzun ve en kalın kemiğidir. Bu çalışma, cerrahi işlemler, ortez ve protez uygulamaları, humerusta morfometrik ve antropometrik ölçümler için bir kriter olacaktır.Gereç ve yöntem: Bu çalışma, 80 (56 sol, 24 sağ) kuru humerus kemik örneklerinde 0.01 milimetre (mm) hassasiyetinde dijital kumpas kullanılarak yapıldı. Kemik örneklerinde yaş ve cinsiyet ayrımı yapılmadı. Humerus üzerinde sulcus intertubercularis uzunluğu, minimum gövde çapı, maksimum gövde çapı, kapitulum humer, troclea humeri gibi 21 parametre ölçüldü.Bulgular: Çalışmamızın sonuçlarına göre humerusun maksimum uzunluğu (HMU); solda ortalama 31,16 ± 2,44 mm ve sağda 29,85 ± 3,08 mm. Minimum gövde çapı (MinGW); Solda 17,62 ± 2,18 mm ve sağda 17,84 ± 1,82 mm’dir.Sonuç: Humerus kemiğinin normal anatomik yapısını bilmek ve bu bölgedeki cerrahi prosedürleri ve protez uygulamalarını yönlendirmek için bu kemikteki anatomik yapıların ortalama değerlerini hesaplamak çok önemlidir. Introduction: Humerus; It is located between the scapula, radius and ulna bones and is the longest and thickest bone of the upper extremity. This study will be a criterion for surgical procedures, orthosis and prosthesis applications, morphometric and anthropometric measurements on humerus.Materials and methods: This study was carried out using digital calipers with sensitivity of 0.01 millimeters (mm) on dry humerus bone specimens of 80 (56 left, 24 right). Age and sex were not differentiated in bone samples. Sulcus intertubercularis length, minimum trunk diameter, maximum trunk diameter, capitulum humer, troclea humer were measured on the humerus as 21 parameters.Results: According to the results of our study, the maximum length of the humerus (HMU); mean 31.16 ± 2.44 mm on the left and 29.85 ± 3.08 mm on the right. Minimum body diameter (MinGW); 17,62 ± 2,18 mm on the left and 17,84 ± 1,82 mm on the rightConclusion: It is very important to know the normal anatomical structure of the humerus bone and to calculate the average values of the anatomical structures on this bone in order to guide the surgical procedures and prosthesis applications in this region.